CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response.
Wegman
Pia P
PP
Wingren
Sten
S
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D005260:Female; D006801:Humans; D018579:Patient Selection; D011379:Prognosis; D015203:Reproducibility of Results; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6